MOC/CME

Provider health and wellness involves multiple issues, including provider stress, burnout and depression, which can lead to medical errors, early retirement, addiction, divorce and suicide. It has been shown that burnout issues start in medical school and progress through residency, fellowship and throughout a provider’s career. Many medical schools, residencies and allergy/immunology fellowships do not spend a lot of time on this issue during training, and, given the modern health care climate, physician/provider health and wellness is likely to continue becoming a more significant issue. This symposium will review the scientific literature about provider health and wellness and discuss the major causes of provider burnout and stress, along with potential solutions to alleviate this burden. Specific data regarding this topic among allergists/immunologists will be reviewed. This session can help allergy/immunology providers throughout their careers.

Moderators: Travis A. Miller, MD, FACAAI, and Andrew Nickels, MD, FACAAI

ARS MOC/CME

From skin-deep to outward, this session will discuss the etiology, management and evaluation of patients with severe cutaneous drug eruptions.

Moderators: Leonard Bielory, MD, FACAAI, and Joseph A. Bellanti, MD, FACAAI

MOC/CME

Several new interventions are likely to be approved by the FDA in the upcoming year. These therapies have different levels of efficacy and side effects and will likely greatly impact office flow. Thus, it is imperative that allergists become more facile with their knowledge regarding these therapies.

Moderators: John J. Oppenheimer, MD, FACAAI, and Marcus Shaker, MD, MSc, FACAAI

MOC/CME

The advent of targeted therapies and further understanding of the microbiome offer exciting opportunities for new approaches to patients with asthma and allergic conditions. However, knowledge gaps continue to exist. This session will review what we've learned, what we have yet to learn and, most importantly, what can be implemented now.

Moderator: Mark L. Corbett, MD, FACAAI

MOC/CME

Any allergist that mixes allergy vaccines should be following the guidance of USP 797. Recent issues, unrelated to allergy vaccine preparation, have caused the USP to alter its requirements for drug compounding. Though initially allergy mixing seemed as though it might be consumed by the “compounding” controversy, the ACAAI and others worked to demonstrate the differences between mixing allergy vaccines in an allergist’s office and the compounding of pharmaceuticals by commercial compounding companies. Although the efforts of the ACAAI Advocacy Council and others were largely successful, changes to the USP 797 requirements for the mixing of allergy vaccines did occur. This symposium will review the history of the issue, address the changes and suggest operational recommendations for implementation of these changes.

Moderators: Richard G. Gower, MD, FACAAI, and Erika Gonzalez-Reyes, MD, FACAAI

ARS MOC/CME

Clinicians are often presented with patients complaining of recurrent infections; however, basic workup including serum immunoglobulins and specific antibodies may fail to demonstrate evidence of any immune deficiency. This clinical conundrum will review the presentation of these causes and the diagnostic workup. Treatment may include supportive therapies, and this clinical conundrum will review treatment options.

Moderators: Sami L. Bahna, MD, DrPh, FACAAI

MOC/CME

The technology involved in telemedicine, direct-to-consumer platforms and case examples of actual technology will be discussed and reviewed. This expert presentation will spark your interest in exploring the future of telemedicine.

Moderators: Jay M. Portnoy, MD, FACAAI, and Justin C. Greiwe, MD, FACAAI

MOC/CME

Our changing climate has impacted not only our temperatures, but the onset and duration of pollen season as well. It is important for allergists to understand the impact that climate change is having on our patients and to anticipate changes to how we provide care. Natural disasters create many challenges and are extremely disruptive to people’s lives. An often-neglected aspect of natural disasters includes the impact that flooding, fires and severe weather can have on the health of people with asthma and allergic conditions. Allergists who care for patients in natural disaster-prone areas can help them prepare for when those disasters strike.

Moderators: William K. Dolen, MD, FACAAI, and Meagan W. Shepherd, MD, FACAAI

MOC/CME

This session will provide a foundation for exploring newer medical, surgical and biologic therapies for chronic rhinosinusitis (CRS) with and without nasal polyps. Etiology, diagnosis and management will be reviewed.

Moderators: Alan B. Goldsobel, MD, FACAAI, and Puneet Shroff, MD, FACAAI